Kiora Pharmaceuticals (KPRX) Return on Sales (2016 - 2025)

Kiora Pharmaceuticals' (KPRX) quarterly Return on Sales came in at 0.0% in Q4 2024, down 35.23% on a QoQ basis from 0.0% in Q3 2024.

Kiora Pharmaceuticals (KPRX) Return on Sales (2016 - 2025) Analysis & Trends

Kiora Pharmaceuticals (KPRX) has 7 years of Return on Sales data on file, last reported at 0.0% in Q4 2024.

Quarterly Return on Sales changed N/A year-over-year to 0.0% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 0.0% (changed N/A YoY) and the FY2024 annual result came in at 0.0%, changed N/A from the prior year.
Return on Sales eased to 0.0% in Q4 2024, from 0.0% in the prior quarter.
In the past five years, Return on Sales ranged from a high of 0.01% in Q1 2024 to a low of 11.1% in Q3 2023.
A 3-year average of 4.03% and a median of 0.49% in 2020 frame the typical range for Return on Sales.
Annual changes were most pronounced in 2020 — Return on Sales tumbled 96 bps — and 2024, when it soared 1110 bps.
Tracing KPRX's Return on Sales over 3 years: stood at 0.97% in 2020, then tumbled by 1040 bps to 11.1% in 2023, then soared by 100 bps to 0.0% in 2024.
The last three Return on Sales figures came in at 0.0% (Q4 2024), 0.0% (Q3 2024), and 0.0% (Q2 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROS (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	0.00%
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	0.00%
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	0.00%
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-0.05%
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	0.00%
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	0.00%
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	0.00%
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	0.00%
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	0.00%
10	Kiora Pharmaceuticals	15.64 Mn	15.64 Mn	-	-

Download Data